Moolec Science (MLECW) Operating Expenses (2022 - 2024)
Moolec Science (MLECW) posted Operating Expenses of -$1.5 million for Q4 2024, up 28.72% sequentially from -$2.1 million in Q3 2024, and up 97.83% YoY from -$750607.8 in Q1 2024.
Moolec Science (MLECW) Operating Expenses (2022 - 2024) Analysis & Trends
Moolec Science has reported Operating Expenses for 3 years, with the latest figure at -$1.5 million in Q4 2024.
- Quarterly Operating Expenses rose 97.83% year-over-year to -$1.5 million in Q4 2024, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (changed N/A YoY) and the FY2024 annual result came in at -$135.6 million, down 11.71% from the prior year.
- Operating Expenses rose to -$1.5 million in Q4 2024 per MLECW's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $69.2 million in Q1 2024 and troughed at -$134.3 million in Q2 2024.
- A 3-year average of -$28.9 million and a median of -$2.2 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 1416.9% in 2023, then jumped 6083.64% in 2024.
- Over 3 years, Operating Expenses stood at -$4.5 million in 2022, then tumbled by 1416.9% to -$68.3 million in 2023, then jumped by 97.83% to -$1.5 million in 2024.
- According to Business Quant data, Operating Expenses over the past three periods registered -$1.5 million, -$2.1 million, and -$134.3 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -134.28 Mn |
| Mar 31, 2024 | 69.25 Mn |
| Dec 31, 2023 | -68.28 Mn |
| Sep 30, 2023 | -2.31 Mn |
| Jun 30, 2023 | -115.42 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | -687,497.00 |
| Jun 30, 2022 | -88.55 Mn |
| Mar 31, 2022 | 176,161.00 |